AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2%

Fri, 5 Jun

AUROBINDO PHARMA has announced its results for the quarter ended March 2020. Here is a detailed performance review of the same:

AUROBINDO PHARMA Quarterly Financials

No. of Mths Qtr. Ending		3 Mar-19*	3 Dec-19*	3 Mar-20*	QoQ Change	YoY Change
Net Sales	Rs m	52,922	57,994	61,584	6.2%	16.4%
Other income	Rs m	323	309	326	5.4%	1.0%
Turnover	Rs m	53,245	58,304	61,910	6.2%	16.3%
Expenses	Rs m	42,347	46,870	48,422	3.3%	14.3%
Gross profit	Rs m	10,215	11,951	13,285	11.2%	30.1%
Depreciation	Rs m	1,866	2,501	2,324	-7.1%	24.5%
Interest	Rs m	501	371	318	-14.2%	-36.4%
Profit before tax	Rs m	8,170	9,388	10,968	16.8%	34.2%
Tax	Rs m	2,311	2,329	2,285	-1.9%	-1.1%
Profit after tax	Rs m	5,859	7,060	8,683	23.0%	48.2%
Gross profit margin	%	19.3	20.6	21.6
Effective tax rate	%	28.3	24.8	20.8
Net profit margin	%	11.0	12.1	14.0

Year-on-Year Performance:

• The company's operating income during the quarter grew 16.4% on a year-on-year (YoY) basis. The expenses were up by 14.3% YoY during the same period.
• The company's operating profit increased by 30.1% YoY during the quarter. Consequently, operating profit margins witnessed a growth and stood at 21.6% in 4QFY20 as against 19.3% in 4QFY19.
• Depreciation charges increased by 24.5% and finance costs declined by 36.4% YoY, respectively.
• Other income increased by 1.0% YoY during the quarter.
• Net profit for the quarter increased by 48.2% YoY. Net profit margins during the quarter increased from 11.0% in 4QFY19 to 14.0% in 4QFY20.

Quarter-on-Quarter Performance:

• The company's operating income during the quarter grew 6.2% on a quarter-on-quarter (QoQ) basis. The expenses were up by 3.3% QoQ during the same period.
• The company's operating profit increased by 11.2% QoQ during the quarter. Consequently, operating profit margins witnessed a growth and stood at 21.6% in 4QFY20 as against 20.6% in 3QFY19.
• Net profit for the quarter increased by 23.0% QoQ, while net profit margins increased from 12.1% in 3QFY19 to 14.0% in 4QFY20.

To see how AUROBINDO PHARMA has performed over the last eight quarters,please visit here.

Access Now: Eight Steps to Your Eight Figure Fortune

AUROBINDO PHARMA Share Price Performance

Over the last one year,AUROBINDO PHARMA share price has moved up from Rs 654.1 to Rs 765.3, registering a Gain of Rs 111.2 or around 17.0%.

Meanwhile, the S&P BSE HEALTHCARE Index is trading at Rs 16,273.6 (up 1.1%). Over the last one year it has moved up from 13,292.6 to 16,273.6, a gain of 2,981 points (up 22.4%).

Overall, the S&P BSE SENSEX is down 14.4% over the year.

Current Valuations

At the current price of Rs 765.3, the price to earnings (P/E) ratio of AUROBINDO PHARMA stands at 15.7 times its trailing twelve months earnings, while its price to book value (P/BV) ratio stands at 3.2 times.